Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76dd75c94c-vpfzz Total loading time: 0 Render date: 2024-04-30T09:53:50.168Z Has data issue: false hasContentIssue false

Chapter 15 - Prenatal Diagnosis

Published online by Cambridge University Press:  29 September 2017

By
Heather Anaya  and
Alexandria Betz
Edited by
Martin Olsen
Martin Olsen
Affiliation:
East Tennessee State University
Get access
Type
Chapter
Information
Obstetric Care , pp. 143 - 149
Publisher: Cambridge University Press
Print publication year: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Driscoll, D, Gross, S. Prenatal screening for aneuploidy. N Engl J Med 2009 ;360:2556–2562.CrossRefGoogle ScholarPubMed
American Congress of Obstetricians and Gynecologists: Screening for Fetal Chromosomal Abnormalities, 2007 Jan. Practice Bulletin: 77.Google Scholar
Palomaki, GE, Kloza, EM, Lambert-Messerlian, GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genet Med 2011 Nov;13:913–20.Google Scholar
Offerdal, K, Blaas, H, Eik-Nes, S. Prenatal detection of trisomy 21 by second-trimester ultrasound examination and maternal age in a non-selected population of 49 314 births in Norway. Ultrasound Obstet Gynecol 2008;32:493–500.CrossRefGoogle Scholar
Centers for Disease Control and Prevention. Division of Birth Defects and Developmental Disabilities; 2016.Google Scholar
Caughey, AB, Hopkins, LM, Norton, ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006;108: 612–616.CrossRefGoogle ScholarPubMed
Nicolaides, KH, Snijders, RJ, Gosden, CM, Berry, C, Campbell, S. Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 1992;340:704–707.Google Scholar
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. Philadelphia: Elsevier Saunders; 2009. p. 227.Google Scholar
Souka, AP, Snijders, RJ, Novakov, A, et al. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11:391.Google Scholar
Snijders, RJ, Noble, P, Sebire, N, Souka, A, Nicolaides, KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet 1998;352:343–346.Google Scholar
Souka, AP, Snijders, RJ, Novakov, A, et al. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency thickness at 10–14 weeks of gestation. Ultrasound Obstet Gynecol 1998; 11:391.CrossRefGoogle ScholarPubMed
Makrydimas, G, Sotiriadis, A, Huggon, IC, et al. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005;192:89–95.Google Scholar
Dugoff, L, Hobbins, JC, Malone, FD, et al. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (the FASTER Trial). Am J Obstet Gynecol 2004;191:1446–1451.Google Scholar
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA;2009.p. 229.Google Scholar
Malone, FD, Canick, JA, Ball, RH, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N Engl J Med 2005;353:2001–2011.Google Scholar
Wapner, RJ, Thom, E, Simpson, JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349:1405–1413.CrossRefGoogle ScholarPubMed
Norton, M, Brar, H, Weiss, J, Karimi, A, et al. Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;137:1–8.Google Scholar
Society for Maternal-Fetal Medicine (SMFM): Prenatal aneuploidy screening using cell-free DNA, 2015 Jun. No. 36.Google Scholar
American Congress of Obstetricians and Gynecologists: Update on Carrier Screening for Cystic Fibrosis, 2011 April. No. 486.Google Scholar
American Congress of Obstetricians and Gynecologists: Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent, 2009 Oct. No. 482.Google Scholar
Wapner, RJ, Thom, E, Simpson, JL, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349:1405–1413.CrossRefGoogle ScholarPubMed
Cuckle, HS, Malone, FD, Wright, D, et al. Contingent screening for Down syndrome – results from the FaSTER trial. Prenat Diagn 2008;28:89–94.CrossRefGoogle ScholarPubMed
Malone, F, Canick, JA, Ball, RH, et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. N Engl J Med 2005;353:2001–2011.CrossRefGoogle ScholarPubMed
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2009. p. 225.Google Scholar
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 7th rev. ed. PA; 2014. p. 340.Google Scholar
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2014.p. 334.Google Scholar
O’Brien, JE, Dvorin, E, Drugan, A, et al. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. Obstet Gynecol 1997; 89:355.CrossRefGoogle ScholarPubMed
Wald, NJ, Cuckle, H, Boreham, J, et al. Maternal serum alpha-fetoprotein and diabetes mellitus. Br J Obstet Gynaecol 1979; 86:101.CrossRefGoogle ScholarPubMed
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2009. p. 234.Google Scholar
Crandall, BF, and Matsumoto, M: Routine amniotic fluid alphafetoprotein assay: experience with 40,000 pregnancies. Am J Med Genet 1986; 24:143.Google Scholar
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2009. p. 235.Google Scholar
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2009. p. 234.Google Scholar
Crandall, BF, Robinson, L, and Grau, P. Risks associated with an elevated maternal serum alpha-fetoprotein level. Am J Obstet Gynecol 1991;165:581.Google Scholar
Kuller, JA, Sellati, LE, Chescheir, NC, et al. Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin. Am J Perinatol 1995; 12:93.Google Scholar
Craig, W, Palomaki, G, Roberson, M, Haddow, J. Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester. Prenatal Diagnosis 2011; 31:616–618.Google Scholar
Craig, WY, Haddow, JE, Palomaki, GE, et al. Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome. Prenat Diagn 2006;26:842.Google Scholar
American Congress of Obstetricians and Gynecologists: Invasive Prenatal Testing for Aneuploidy. 2007 Dec. Practice Bulletin: 88.Google Scholar
Chorionic villus sampling and amniocentesis: recommendations for prenatal counseling. Centers for Disease Control and Prevention. MMWR Recomm Rep 1995;44.Google Scholar
Jackson, LG, Zachary, JM, Fowler, SE, Desnick, RJ, Golbus, MS, Ledbetter, DH, et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med 1992;327:594–598.Google Scholar
Caughey, AB, Hopkins, LM, Norton, ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006;108:612–616.CrossRefGoogle ScholarPubMed
Eddleman, KA, Malone, FD, Sullivan, L et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006;108:1067–1072.Google Scholar
Mazza, V, Pati, M, Bertucci, E, et al. Age-specific risk of fetal loss post second trimester amniocentesis: analysis of 5,043 cases. Prenat Diagn 2007;27:180–183.Google Scholar
Marthin, T, Liedgren, S, Hammar, M. Transplacental needle passage and other risk-factors associated with second trimester amniocentesis. Acta Obstet Gynecol Scand 1997 ;76:728–732.CrossRefGoogle ScholarPubMed
Borgida, AF, Mills, AA, Feldman, DM, Rodis, JF, Egan, JF. Outcome of pregnancies complicated by ruptured membranes after genetic amniocentesis. Am J Obstet Gynecol 2000;183:937–939.CrossRefGoogle ScholarPubMed
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2009.p. 249.Google Scholar
Sawa, R, Hayashi, Z, Tanaka, T, et al. Rapid detection of chromosome aneuploidies by prenatal interphase FISH and its clinical utility in Japan. J Obstet Gynecol Res 2001;27:41–47.CrossRefGoogle ScholarPubMed
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2009. p. 256.Google Scholar
Creasy, R, Resnik, R, Iams, J, Lockwood, C, Moore, T. Creasy & Resnik’s Maternal-Fetal Medicine Principles and Practice. 6th rev. ed. PA; 2009. p. 257.Google Scholar
Berghella, V. Maternal-Fetal Evidence Based Guidelines. 2nd ed. UK; 2012. p. 348.Google Scholar
Lipitz, S, Achiron, R, Zalel, Y, Mendelson, E, Tepperberg, M, Gamzu, R. Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet Gynecol 2002;100:428–433.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×